Work

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes

Year: 2011

Type: article

Study design: Observational Study

Source: Kidney International

DOI: 10.1038/ki.2011.188

Authors: Yi Zhang, Mae Thamer, James S. Kaufman, Dennis J. Cotter, Miguel A. Hernán

Institutions: Medical Technology and Practice Patterns Institute, VA Boston Healthcare System, Harvard University

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, Agency for Healthcare Research and Quality, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Epoetin Therapy and Survival of Hemodialysis Patients, INDIVIDUALIZED TREATMENT STRATEGIES AND OPTIMAL HEMATOCRIT TARGET FOR COMPLEX DIA, G5128933203, Estimating Effects of Interventions in Longitudinal Data, G8103398324

OpenAlex ID: W2073613013

FWCI: 4.598

Cites: 30

Cited by: 47

Related to: 10